Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
Published October 28, 2026 · Recall initiated: September 29, 2026
Summary
FDA records drug Class II recall D-0051-2027, published October 28, 2026 and initiated September 29, 2026. Recalling firm: Pfizer; Status: Ongoing; Reported quantity: 134 1000-count bottles; Lot: Lot # 24W07, Exp: 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOXYL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOXYL
- Manufacturer
- Pfizer
- Distributor
- US Nationwide and Puerto Rico
- UPC
- 0360793858012
- Lot
- Lot # 24W07, Exp: 11/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed byOctober 28, 2026
- FDAHeparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by:October 28, 2026
- FDATelmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: MylanOctober 28, 2026
- FDALevoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc.,August 20, 2025
- FDALEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc., New York, NY 10017, MADEJune 2, 2021
- FDALevoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by PfizerDecember 26, 2018
Questions about this recall
Was Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10 recalled?
Yes. FDA published recall D-0051-2027 on October 28, 2026. Reported hazard: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOXYL. UPC: 0360793858012.